1. Epigenetics Cell Cycle/DNA Damage Apoptosis
  2. Epigenetic Reader Domain PARP Apoptosis
  3. PARP1/BRD4-IN-2

PARP1/BRD4-IN-2 是一种有效且具有选择性的 PARP1BRD4 抑制剂,IC50 分别为 197 nM 和 238 nM。PARP1/BRD4-IN-2 抑制 DNA 损伤修复,阻止 G0/G1 细胞周期转变,诱导细胞凋亡 (apoptosis)。PARP1/BRD4-IN-2 在MDA-MB-468小鼠异种移植瘤模型中具有抗肿瘤活性。PARP1/BRD4-IN-2 可用于三阴性乳腺癌 (TNBC) 的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

PARP1/BRD4-IN-2 Chemical Structure

PARP1/BRD4-IN-2 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PARP1/BRD4-IN-2 is a potent and selective PARP1 and BRD4 inhibitor with IC50 values of 197 nM and 238 nM, respectively. PARP1/BRD4-IN-2 inhibits DNA damage repair, arrests G0/G1 transition and induces apoptosis. PARP1/BRD4-IN-2 has anti-tumor activity in MDA-MB-468 xenograft mouse model. PARP1/BRD4-IN-2 can be used for researching triple-negative breast cancer (TNBC)[1].

IC50 & Target[1]

BRD4

238 nM (IC50)

PARP1

197 nM (IC50)

体外研究
(In Vitro)

PARP1/BRD4-IN-2 (compound BP44) can directly bind to BRD4 and PARP1 in MDA-MB-468 cells and improve their thermal stability[1].
PARP1/BRD4-IN-2 has antiproliferative activity against MDA-MB-231 and MDA-MB-468 with IC50s of 6.61±0.58 μM and 3.01±0.83 μM, respectively[1].
PARP1/BRD4-IN-2 (5, 10, and 20 μM) down-regulates Bcl-2 and up-regulates Bax and cleaved caspase3 at 20 μM; inhibits colony formation and promotes cell apoptosis in MDA-MB-468 cells[1].
PARP1/BRD4-IN-2 (5, 10, and 20 μM) down-regulates DNA damage-related proteins CtIP, Mre11, Rad51, and p-RPA32 dose-dependently; causes DNA damage repair defects by down-regulating Rad51 and p-RPA32[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

PARP1/BRD4-IN-2 (40 and 80 mg/kg; IG, for 16 days) significantly inhibits tumor growth in xenograft mice and without significant toxicities, and significantly down-regulates the expression of CtIP, c-Myc, PAR, and Rad51 in tumor tissues[1].
Pharmacokinetic Parameters of PARP1/BRD4-IN-2 in Sprague-Dawley rats[1].

IV (1 mg/kg) PO (10 mg/kg)
T1/2 (h) 3.02 ± 0.57 3.33 ± 0.71
Cmax (ng/mL) 258 ± 11 242 ± 6
AUC0-t (ng/mL·h) 629 ± 49 1489 ± 130
AUC0-∞ (ng/mL·h) 642 ± 36 1530 ± 146
VZ (L/kg) 21.1 ± 2.6
CL (mL/min/kg) 33.7 ± 1.5
F (%) 23.8 ± 1.3

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female BALB/c nude mice (implanted subcutaneously with MDA-MB-468 tumor cells)[1]
Dosage: 40 and 80 mg/kg
Administration: IG, for 16 days
Result: Significantly inhibited tumor growth and exhibits no significant toxicities; and significantly down-regulated the expression of CtIP, c-Myc, PAR, and Rad51 in tumor tissues.
分子量

440.45

Formula

C25H20N4O4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
PARP1/BRD4-IN-2
目录号:
HY-150613
需求量: